Denemek ALTIN - Özgür

Healing an Ailing MedTech Talent Ecosystem

BioSpectrum Asia

|

BioSpectrum Asia April 2025

The Asia-Pacific (APAC) region represents a critical landscape for the future of medical technology. However, a thriving medical technology sector needs people skilled in engineering, product development and manufacturing. With advances in artificial intelligence (AI) and robotic surgeries driving a big transformation and creating new opportunities, it is also deepening the skills gap many workers face. Let's take a closer look at these gaps and the solutions that are emerging to address those gaps.

- Vrushti Kothari

Healing an Ailing MedTech Talent Ecosystem

The demand for personalised and efficient healthcare is on the rise and the medical technology (medtech) industry is booming within the APAC region. But at the same time, the region is faced with an ageing population and a growing burden of disease, exacerbated by limited healthcare infrastructure and manpower.

Further, the region is witnessing accelerated adoption of artificial intelligence (AI), robotics, 3D printing, and smart diagnostics, reshaping healthcare delivery and patient outcomes. Both the public and private sectors across APAC countries are investing in the growing adoption of new technologies to strengthen the MedTech sector.

If we look closely, individual countries within the APAC region have distinct technological strengths and capabilities. For instance, China and India stand out for their vast technical talent pools, while Japan and South Korea are notable for having a large pool of users for AI-enabled solutions; and Singapore and Australia are recognised for their well-established healthcare data infrastructure and strong capabilities in AI development.

imageHowever, workers within the medtech often lack access to the necessary training or educational resources required to adopt the new skills. This digital divide has led to a growing demand for scalable and accessible upskilling initiatives. Thus, the medtech sector within the APAC region must prepare their workforces for a technology-driven future in order to realise economic growth, social equity and innovation, to avoid wage gaps, trade imbalances and security threats.

BioSpectrum Asia'den DAHA FAZLA HİKAYE

BioSpectrum Asia

BioSpectrum Asia

Waters launches charge detection mass spectrometry technology

US-based Waters Corporation has unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering unmatched measurement and characterisation for the broadest range of mega-mass biomolecules central to next-generation therapeutics and structural biology.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

Chulalongkorn University launches Thailand's first master's programme in Nurse Anesthesia

The Faculty of Nursing, Chulalongkorn University, has officially launched the \"Master of Nursing Science Programme in Nurse Anesthesia\" - the first of its kind in Thailand.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

WHO strengthens coordination for NTD programmes and supply chain delivery

The World Health Organization (WHO), together with health ministries, pharmaceutical donours, implementing partners and technical support platforms, is strengthening coordination for neglected tropical disease (NTD) programmes and supply chain delivery, through three major back-to-back meetings in Geneva.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

All-in-one coronavirus vaccines to save millions in future pandemics

A new study reveals that vaccines designed to protect against a wide range of coronaviruses could dramatically reduce deaths and economic disruption and limit the need for lockdowns in the event of another global coronavirus pandemic.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

NTU in Singapore introduces Master of Science course in Chinese Medicine

From 2026, Nanyang Technological University (NTU) in Singapore will start offering a Master of Science in Chinese Medicine to develop highly skilled postgraduates with advanced expertise in both the theoretical foundations and practical applications of Chinese medicine.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

ProSpecBio launches Activin-A recombinant protein for brain injury research

Israel-based ProSpecBio, an evolving biotech company dedicated to providing highly purified proteins to the global research community, has announced the launch of its latest product: CHO cell-derived recombinant Activin-A, now available for immediate delivery worldwide.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

PAHO publishes guide for designing AI instructions in public health

The Pan American Health Organization (PAHO) has launched a new guide providing practical advice on how to create Artificial Intelligence (AI) prompts that generate reliable, relevant, and culturally appropriate content across diverse contexts.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

Prerna launches India's first MicroRNA based blood test for breast cancer screening

Precision RNA Biotech (Prerna), a healthcare startup from Hyderabad, India has announced the launch of Cantel, India's first microRNA-based blood test for breast cancer screening.

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

Poly Medicure announces acquisition of Citieffe Group for Rs 324 Cr

India-based medtech firm Poly Medicure has announced signing of a definitive agreement to acquire 100 per cent stake in Medistream SA (Group) consisting of Citieffe SRL and its step-down subsidiaries in USA & Mexico, at an Enterprise Value of Rs 324 crore (EUR 31 million).

time to read

1 min

BioSpectrum Asia Nov 2025

BioSpectrum Asia

BioSpectrum Asia

Sumitomo, Novo Nordisk to co-promote obesity drug Wegovy in Japan

Sumitomo Pharma and Novo Nordisk Pharma have entered into a co-promotion agreement in Japan for Wegovy Subcutaneous Injection, a once-weekly subcutaneous injection formulation of GLP-1 receptor agonist indicated for the treatment of obesity disease.

time to read

1 min

BioSpectrum Asia Nov 2025

Listen

Translate

Share

-
+

Change font size